Zynex, Inc. (NASDAQ: ZYXI) is a medical device company specializing in non-invasive therapeutic and monitoring technologies. The company’s primary focus is on electrotherapy, pain management, and cardiac monitoring solutions that serve patients in clinical settings as well as in homecare environments. Zynex develops, manufactures, and markets a suite of products designed to alleviate chronic pain, aid in rehabilitation, and provide continuous cardiac data to healthcare professionals.
The company’s offerings are organized into three core segments. In Pain Management, Zynex provides electrotherapy devices that deliver electrical stimulation to reduce pain and promote tissue healing. Its Neurostimulation segment features devices for stroke rehabilitation and motor recovery by stimulating nerve pathways. The Cardiac Monitoring division offers ambulatory ECG solutions, enabling extended monitoring of heart activity and timely detection of arrhythmias and other cardiac events. Many of these products include proprietary software for data analysis and remote patient monitoring.
Founded in 1996 and headquartered in Englewood, Colorado, Zynex initially focused on physical therapy and rehabilitation. Over the years, the company expanded its technology portfolio and distribution network, establishing direct-to-patient sales, partnerships with healthcare providers, and collaborations with third-party administrators. Zynex’s devices are cleared by the U.S. Food and Drug Administration and are distributed throughout the United States, with support operations in key regional offices to facilitate customer training and technical support.
The company’s leadership team is led by Chairman and Chief Executive Officer James E. Walker, who has overseen product innovation and strategic growth initiatives. Under his direction, Zynex has launched next‐generation devices, enhanced its digital health capabilities, and strengthened its reimbursement processes. The management team also includes experienced executives in operations, clinical affairs, and regulatory compliance, collectively guiding the company’s efforts to deliver quality care solutions and expand its presence in the competitive medical device market.
AI Generated. May Contain Errors.
Free ZYXI Stock Alerts